Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Breast cancer, female
Stage/Subtype:  breast cancer in situ
Results 1-25 of 41 for your search:
Start Over
Safety and Efficacy Study of the Xoft® Axxent® eBx™ IORT System
Phase: Phase IV
Type: Treatment
Age: 40 and over
Trial IDs: CTPR-0009, NCI-2013-01601, NCT01644669
Treating Mild or Moderate Lymphedema in Women Who Have Undergone Treatment for Breast Cancer
Phase: Phase III
Type: Supportive care
Age: 18 and over
Trial IDs: 08-308, NCI-2009-01263, NCT00959985
Yoga or Stretching and Relaxation in Improving Physical Function in Patients with Stage 0-III Breast Cancer Undergoing Radiation Therapy
Phase: Phase III
Type: Supportive care
Age: 18 and over
Trial IDs: 2009-0976, NCI-2012-01895, NCT01202851
Bioimpedance Spectroscopy in Quantification of Lymphedema in Patients With Breast Cancer
Phase: Phase III
Type: Diagnostic
Age: 18 and over
Trial IDs: 11-325, NCI-2012-00144, NCT01544335
Metformin Hydrochloride in Preventing Breast Cancer in Patients with Atypical Hyperplasia or In Situ Breast Cancer
Phase: Phase III
Type: Biomarker/Laboratory analysis, Prevention, Treatment
Age: 25 to 55
Trial IDs: A211102, NCI-2013-00995, CALGB-A211102, NCT01905046
Therapeutic Melatonin in Treating Cancer-Related Fatigue in Breast Cancer Patients Undergoing Radiation Therapy
Phase: Phase III
Type: Supportive care
Age: 18 and over
Trial IDs: MCC-12-08248, NCI-2015-00345, NCI-2015-00317, NCT02332928
Study of the Efficacy of Chloroquine in the Treatment of Ductal Carcinoma in Situ (The PINC Trial)
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: IFHCC 09-002, NCI-2014-01429, NCT01023477
Single Fraction High-Gradient Partial Breast Irradiation in Treating Patients With Low-Risk Stage 0-I Breast Cancer
Phase: Phase II, Phase I
Type: Treatment
Age: 50 and over
Trial IDs: 201401160, NCI-2014-00269, NCT02076074
VST-1001 (Dilute Fluorescein) for Lymphatic Mapping & Localization of Lymph Nodes in Patients With Breast Cancer
Phase: Phase II, Phase I
Type: Diagnostic
Age: 18 and over
Trial IDs: VST-1001-02, NCI-2014-02431, 2013-1021, NCT02294565
Accelerated Whole Breast Radiotherapy in Treating Patients with Breast Cancer Who Have Undergone Surgery
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 040807, NCI-2012-00535, CDR0000643276, CINJ-040807, NCT00909909
Laboratory Treated T Cells after Chemotherapy in Treating Patients with HER2-Negative Stage II-III Breast Cancer That Can Be Removed by Surgery
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 2010-056, NCI-2011-02634, 1005008403, CDR0000675211, NCT01658969, WSU-2010-056, NCT01147016
Radiation Therapy in Treating Patients With Breast Cancer
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 2009-0818, NCI-2011-01102, NCT01245712
Letrozole in Treating Postmenopausal Women with Ductal Carcinoma in Situ
Phase: Phase II
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Age: 18 and over
Trial IDs: CALGB 40903, NCI-2011-03452, CDR0000701992, NCT01439711
Yoga in Decreasing Inflammation, Fatigue, and Depressive Symptoms in Breast Cancer Survivors
Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care
Age: 21 and over
Trial IDs: OSU-06137, NCI-2012-00564, 2007C0004, OSU-2007C0004, NCT00486525
Radiation Therapy in Treating Post-Menopausal Women with Early Stage Breast Cancer Undergoing Surgery
Phase: Phase II
Type: Treatment
Age: 50 and over
Trial IDs: I 108907, NCI-2009-01568, NCT01754519
Omega-3 Fatty Acid in Treating Patients with Stage I-III Breast Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: CCCWFU 98113, NCI-2013-00963, NCT01869764
Remote-Based Weight Loss Program in Obese Patients with Breast Cancer
Phase: Phase II
Type: Behavioral study, Biomarker/Laboratory analysis
Age: 18 and over
Trial IDs: SKCCC J12128, NCI-2013-01345, J12128, NA_00080407, NA_00080407 / CIR00000900, NCT01871116
Naltrexone Hydrochloride in Reducing Radiation Therapy Related Fatigue in Patients with Breast Cancer
Phase: Phase II
Type: Supportive care
Age: 18 and over
Trial IDs: 14-056, NCI-2014-02031, NCT02137252
Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing Mastectomy
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: NCI 2013-01-03, NCI-2014-02412, HHSN2612201200035I, N01-CN-2012-00035, NWU2013-01-03, NCT02314156
Imaging Probe LUM015 in Diagnosing Patients with Soft Tissue Sarcoma or Breast Cancer
Phase: Phase I
Type: Biomarker/Laboratory analysis, Diagnostic
Age: 18 and over
Trial IDs: Pro00035444, NCI-2013-00471, DUK1-12-137, NCT01626066
Gene Expression in Blood Samples from High-Risk Postmenopausal Women Who Received Treatment on Breast Cancer Prevention Clinical Trials NSABP-P-1 or NSABP-P-2
Phase: No phase specified
Type: Biomarker/Laboratory analysis
Age: 35 and over
Trial IDs: MC083I, NCI-2009-01112, CDR0000638644, NSABP-MC083I, NCT00967239
High Dose Rate Brachytherapy in Treating Patients with Endometrial, Cervical, Lung, Breast, or Prostate Cancer
Phase: No phase specified
Type: Natural history/Epidemiology, Treatment
Age: 18 to 90
Trial IDs: 09-C-0100, NCI-2013-01448, 090100, P08407, NCT00924027
Radiofrequency Ablation After Breast Lumpectomy in Treating Patients With Breast Cancer
Phase: No phase specified
Type: Treatment
Age: 50 and over
Trial IDs: AAAF3783, NCI-2011-00746, NCT01153035
Pasireotide in Preventing the Spread of Breast Cancer in Patients with Non-Invasive Breast Cancer
Phase: No phase specified
Type: Treatment
Age: 21 and over
Trial IDs: NYU10-00641, NCI-2011-02367, BC097854, i10-00641, R10-00641, NCT01372618
Start Over